Product Images Pregabalin

Pregabalin is a medication in the form of a 225mg capsule, with a quantity of 90. It has an NDC number of 70518-2980-00 and a source NDC of 69238-1316-09, manufactured by Amneal Pharma in India. There is no information on the expiration date or lot number. The directions for use should be found in the package insert, and this medication should be stored between temperatures of 20-26°C (63-77°F), with excursions allowed up to 15-30°C (59-86°F), as per USP. Keep it out of the reach of children. The medication has been repackaged by RemedyRepack Inc. in Indiana.*

This is a formula to calculate Creatinine Clearance (CLCr) which is a measure of kidney function. CLCr is calculated by subtracting age (in years) from 140 and multiplying it by weight (in kilograms). Then, this value is multiplied by 0.85 for female patients. Finally, the result is divided by 72 multiplied by the serum creatinine level (in milligrams per deciliter).*

This seems to be a table showing different doses and types of medication, including Pregabalin, and a placebo, with a percentage of improvement in pain from baseline for each treatment. Not enough context is provided to determine what medical condition this relates to.*

This appears to be a graph that shows the estimated percentage of subjects without LTR (unclear what LTR represents without more context) on the vertical axis and the days on the horizontal axis. The graph appears to show data for Pregabalin and a Placebo group. There are ten data points ranging from 100% to 10%, with no data available for the middle percentage values. The days on the horizontal axis are marked in increments of 20 up to 100, and then again at 120, 140, 160, and 180.*

This is a chart depicting the percentage of subjects who showed improvement over the course of 12 weeks in a study comparing Pregabalin to a placebo. The chart shows two percentages, one at 100 and one at 90. There are also numbers from 220 to 290 listed horizontally along the bottom. Unfortunately, without additional context or information, it is difficult to determine the exact meaning of the chart.*

The text provided does not offer enough context to generate a useful description. It appears to be a graph or chart with data points, percentages, and dates. Without more information, a specific description cannot be provided.*

The text seems to be a report showing the percentage of patients who have improved over time, as measured from a baseline. However, some parts of the text were not recognized by and appear as gibberish.*

Not available.*

This is a report showing the percentage of patients who experienced improvement in pain after taking either Pregabaline 100mg three times a day, Pregabalin 0mg three times a day or Placeta. The report also displays the percentage of improvement in pain from the baseline.*